Beeline Medicines

Sign in

Open roles

  • Beeline Medicines logo
    Global Pharmacovigilance Medical Director

    Beeline Medicines

    • United States
    • Director / Executive
    • $266k–$344k
    Greenhouse
    Posted 12d ago
  • Beeline Medicines logo
    Senior Medical Affairs Operations Manager

    Beeline Medicines

    • Cambridge, MA
    • Hybrid · Senior
    • $165k–$215k
    Greenhouse
    Posted 15d ago
  • Beeline Medicines logo
    Senior Outsourcing Manager

    Beeline Medicines

    • Durham, NC
    • Hybrid · Senior
    • $124k–$160k
    Greenhouse
    Posted 15d ago
  • Beeline Medicines logo
    IT Support Analyst

    Beeline Medicines

    • Cambridge, MA
    • Mid-level
    • $77k–$100k
    Greenhouse
    Posted 23d ago
  • Beeline Medicines logo
    Senior Executive Assistant & Office Operations

    Beeline Medicines

    • Cambridge, MA
    • Hybrid · Senior
    • $113k–$146k
    Greenhouse
    Posted 34d ago
  • Beeline Medicines logo
    Medical Director, Clinical Development

    Beeline Medicines

    • Cambridge, MA
    • Hybrid · Director / Executive
    • $266k–$340k
    Greenhouse
    Posted 34d ago
Show all roles

About

Beeline Medicines logo

Beeline Medicines

Let’s get to what matters. To life lived fully.

Beeline Medicines is a clinical-stage biotechnology company focused on developing and delivering category-leading precision therapies to transform the lives of people living with autoimmune and inflammatory diseases. We are here to chart a new path for patients, rigorously pushing the science forward to deliver therapies that go straight to the drivers of immune dysfunction to define new treatment paradigms. Our portfolio is comprised of therapeutic candidates rooted in validated biology, powered by best-in-class molecular properties, and driven by an efficient clinical development strategy designed for differentiated, lasting impact for patients. Grounded in scientific rigor and driven by purpose, we get to what matters so that people living with immune-mediated diseases can live life fully.

Private companySeries AMega roundBrand new
Founded2025
HQ
Stamford, United States
Size51–200 employees
IndustryBiotechnology Research
Latest fundingSeries A · Jun 30, 2026
Investors
Bain Capital
News
  • Beeline Medicines to Present Results from the Phase 2 Trial of Afimetoran in Systemic Lupus Erythematosus as a Late-Breaking Oral Presentation at ACR Convergence 2026

Claim beelinemedicines.com

Work at beelinemedicines.com? Sign in to claim this org and manage its profile.

ThesisExploreTermsPrivacy
© 2026 Saywise Inc.